The adaptive immunologic microenvironment in colorectal cancer: a novel perspective.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cancer Research

• Publication date

  2007-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-06-4806PMID 17332313
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High levels of heat shock protein Hsp72 in cancer cells suppress default senescence pathways.

  2007cited by this paper
• The Consensus Coding Sequences of Human Breast and Colorectal Cancers

  2006cited by this paper
• Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

  2006cited by this paper
• Interferons, immunity and cancer immunoediting

  2006cited by this paper
• ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.

  2006cited by this paper
• Effector memory T cells, early metastasis, and survival in colorectal cancer.

  2005cited by this paper
• Tumour-educated macrophages promote tumour progression and metastasis

  2004cited by this paper
• Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.

  2004cited by this paper
• Central memory and effector memory T cell subsets: function, generation, and maintenance.

  2004cited by this paper
• The three Es of cancer immunoediting.

  2004influential reference
• Colorectal Carcinoma: Diagnostic, Prognostic, and Molecular Features

  2003cited by this paper
• Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

  2003cited by this paper
• Immunology and immunotherapy of colorectal cancer.

  2003cited by this paper
• Prognostic factors and clinical trials of new agents in patients with metastatic renal cell carcinoma.

  2003cited by this paper
• International Union Against Cancer

  2002cited by this paper
• Inflammation and cancer

  2002cited by this paper
• Emerging pathways in colorectal-cancer development.

  2002cited by this paper
• The microenvironment of the tumour–host interface

  2001cited by this paper
• T cell memory against colon carcinoma is long-lived in the absence of antigen.

  1999cited by this paper
• Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma

  1996cited by this paper
• The classification of cancer of the rectum

  1980cited by this paper
• Immunology and immunotherapy of colorectal cancer.

  1978influential reference
• [Inflammation and cancer].

  1974cited by this paper

• Advances in immunotherapy for colorectal cancer: overcoming resistance in mismatch repair-proficient tumors.

  2026cites this paper
• Breaking Barriers in CRC Immunotherapy: Cutting-Edge Advances in Personalized Peptide Vaccine Development.

  2025cites this paper
• Immune Profiling May Improve Risk Stratification in Early-Stage Colorectal Carcinoma.

  2025cites this paper
• Assessment of inflammatory infiltrate in colorectal carcinoma with a critical evaluation of the different scoring systems and correlation with prognostic parameters.

  2025cites this paper
• Immunogenomic characteristics and prognostic implications of terminally exhausted CD8+ T cells in colorectal cancers

  2025cites this paper
• Synergy between TLR3-ligand and IFN-α in the transient sensitization of “Cold” tumors to PD-1 blockade and the induction of systemic immunity

  2025cites this paper
• Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinoma

  2025cites this paper
• Lymph node threshold in colorectal cancer: surgeons’ perspectives and practices

  2025cites this paper
• Significance of Th1 and Th2 Cell Densities and Th1/Th2 Cytokine Profiles in Colorectal Cancer

  2025cites this paper
• Development and validation of prognostic model based on distribution and density of CD3+ and CD8+ infiltrating lymphocytes in breast cancer: A multicenter cohort study

  2025cites this paper
• Integrative transcriptomic and single-cell protein characterization of colorectal carcinoma delineates distinct tumor immune microenvironments associated with overall survival.

  2025cites this paper
• Beta-2-microglobulin positive tumor cells and CD8 positive lymphocytes are associated with outcome in post-neoadjuvant colorectal cancer resections.

  2025cites this paper
• Construction and validation of a clinicopathologic signature for predicting the prognosis of stage II and III colorectal cancer

  2025cites this paper
• Impact of tertiary lymphoid structure scores and their stage of maturation on prognosis of colorectal cancer patients

  2025cites this paper
• Characterization of Pleural Mesothelioma by Hierarchical Clustering Analyses Using Immune Cells within Tumor Microenvironment

  2024cites this paper
• Integrative Transcriptomic and Single-Cell Protein Characterization of Colorectal Carcinoma Delineates Distinct Tumor Immune Microenvironments Associated with Overall Survival

  2024cites this paper
• Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors

  2024cites this paper
• VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification

  2024cites this paper
• A Graph Curvature-Based Pipeline for Discovering Immune Checkpoint Response Biomarkers

  2024cites this paper
• Molecular subtypes of colorectal cancer in the era of precision oncotherapy: Current inspirations and future challenges

  2024cites this paper
• Risk prediction model of uterine corpus endometrial carcinoma based on immune-related genes

  2024cites this paper
• Prognostic Significance of Cytotoxic T-Lymphocyte CD8+ Immunoscore in Urothelial Carcinoma Bladder

  2024cites this paper
• Discrete Ollivier-Ricci Flow Finds Distinct Subpopulations of Patients Treated with PD-1 Inhibition

  2024cites this paper
• IGF1R inhibition and PD-1 blockade improve anti-tumor immune response in epithelial ovarian cancer

  2024cites this paper
• Effect of colorectal cancer stem cells on the development and metastasis of colorectal cancer

  2024cites this paper
• Prognostic significance of CD3+ and CD8+ T-cells immunoscore in renal cell carcinoma: A comparison between two simple models for assessment.

  2024cites this paper
• Mathematical modeling of interactions between colon cancer and immune system with a deep learning algorithm

  2024cites this paper
• Integrated analysis of tertiary lymphoid structures and immune infiltration in ccRCC microenvironment revealed their clinical significances: a multicenter cohort study

  2024cites this paper
• Immunoarchitectural Pattern and Its Potential Prognostic Value in Mucoepidermoid Carcinoma

  2024cites this paper
• A composite decision rule of CD8+ T cell density in tumor biopsies predicts efficacy in early-stage, immunotherapy trials.

  2023cites this paper
• “Cold” colorectal cancer faces a bottleneck in immunotherapy

  2023cites this paper
• Unique characteristics of the tumor immune microenvironment in young patients with metastatic colorectal cancer

  2023cites this paper
• Dissecting the role of the gut microbiome and fecal microbiota transplantation in radio- and immunotherapy treatment of colorectal cancer

  2023cites this paper
• Characterization of colorectal cancer by hierarchical clustering analyses of five immune cell markers

  2023cites this paper
• Effect of anterior quadratus lumborum block with ropivacaine on the immune response after laparoscopic surgery in colon cancer: a substudy of a randomized clinical trial

  2023cites this paper
• Grid2 interacting protein is a potential biomarker related to immune infiltration in colorectal cancer

  2023cites this paper
• PD-L1 Restrains the PD-1hiNrp1loTGFβ+ Treg to block IL6+ Neutrophil tumor infiltration to Suppress Inflammation-driven Colorectal Cancer

  2023cites this paper
• A neutrophil extracellular traps-related classification predicts prognosis and response to immunotherapy in colon cancer

  2023cites this paper
• Immune microenvironment and lymph node yield in colorectal cancer

  2023cites this paper
• Synergistic effects of ozone with doxorubicin on the proliferation, apoptosis and metastatic profile of luminal-B type human breast cancer cell line.

  2023cites this paper
• Clinical, pathological, genetics and intratumoural immune milieu of micropapillary carcinoma of the colon

  2023cites this paper
• Laparoscopic-Assisted Colorectal Resection Can Reduce the Inhibition of Immune Function Compared with Conventional Open Surgery: A Retrospective Clinical Study

  2023cites this paper
• Immunotherapy with Immune Checkpoint Inhibitors for Advanced Colorectal Cancer: A Promising Individualized Treatment Strategy.

  2023cites this paper
• Bioinformatics analysis and experimental validation identified HMGA2/microRNA-200c-3p/LSAMP/Wnt axis as an immunological factor of patients with colorectal cancer.

  2023cites this paper
• Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response

  2023cites this paper
• M6A RNA methylation modification and tumor immune microenvironment in lung adenocarcinoma

  2023cites this paper
• A signature-based classification of lung adenocarcinoma that stratifies tumor immunity

  2023cites this paper
• China special issue on gastrointestinal tumors‐Regulatory‐immunoscore—A novel indicator to guide precision adjuvant chemotherapy in colorectal cancer

  2023cites this paper
• Translational research of new developments in targeted therapy of colorectal cancer.

  2023cites this paper
• Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer

  2023cites this paper
• Identification of an inflammatory response signature associated with prognostic stratification and drug sensitivity in lung adenocarcinoma

  2022cites this paper
• Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Colon Cancer to Immunotherapy

  2022cites this paper
• Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time?

  2022cites this paper
• Subtype-Specific Tumour Immune Microenvironment in Risk of Recurrence of Ductal Carcinoma In Situ: Prognostic Value of HER2

  2022cites this paper
• Spatial Characterization of Tumor-Infiltrating Lymphocytes and Breast Cancer Progression

  2022cites this paper
• Intratumoral T-cell repertoires in DNA mismatch repair-proficient and -deficient colon tumors containing high or low numbers of tumor-infiltrating lymphocytes

  2022cites this paper
• Latest evidence on immune checkpoint inhibitors in metastatic colorectal cancer: A 2022 update.

  2022cites this paper
• Correlation of clinical, pathologic, and genetic parameters with intratumoral immune milieu in mucinous adenocarcinoma of the colon

  2022cites this paper
• The Prognostic Significance of RIMKLB and Related Immune Infiltrates in Colorectal Cancers

  2022cites this paper
• Predictive preoperative clinical score for patients with liver-only oligometastatic colorectal cancer

  2022cites this paper
• Interleukin-21 and Interleukin-32 gene expression levels and their relationship with clinicopathological parameters in colorectal cancer.

  2022cites this paper
• Landscape of Immunotherapy Options for Colorectal Cancer: Current Knowledge and Future Perspectives beyond Immune Checkpoint Blockade

  2022cites this paper
• Identifying Potential Biomarkers of Prognostic Value in Colorectal Cancer via Tumor Microenvironment Data Mining

  2022cites this paper
• Lung Cancer Immunotherapy: Beyond Common Immune Checkpoints Inhibitors

  2022cites this paper
• The Prognostic Impact of Combined Tumor-Infiltrating Lymphocytes and Pretreatment Blood Lymphocyte Percentage in Locally Advanced Nasopharyngeal Carcinoma

  2022cites this paper
• Monitoring Pre- and Post-Operative Immune Alterations in Patients With Locoregional Colorectal Cancer Who Underwent Laparoscopy by Single-Cell Mass Cytometry

  2022cites this paper
• As a prognostic biomarker of clear cell renal cell carcinoma RUFY4 predicts immunotherapy responsiveness in a PDL1-related manner

  2022cites this paper
• Use of Personalized Biomarkers in Metastatic Colorectal Cancer and the Impact of AI

  2022cites this paper
• Artificial intelligence for quantifying Crohn’s-like lymphoid reaction and tumor-infiltrating lymphocytes in colorectal cancer

  2022cites this paper
• CD8+ T cell-associated genes MS4A1 and TNFRSF17 are prognostic markers and inhibit the progression of colon cancer

  2022cites this paper
• Attackers and defenders: tumor buds and lymphocytes as morphological biomarkers in colorectal cancer

  2022cites this paper
• Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma

  2022cites this paper
• The prognostic value of a 4‐factor neoimmunologic score system in non‐small cell lung cancer

  2022cites this paper
• DDR1 functions as an immune negative factor in colorectal cancer by regulating tumor‐infiltrating T cells through IL‐18

  2022cites this paper
• lncRNAs AC156455.1 and AC104532.2 as Biomarkers for Diagnosis and Prognosis in Colorectal Cancer

  2022cites this paper
• Techniques for Profiling the Cellular Immune Response and Their Implications for Interventional Oncology

  2022cites this paper
• Radiomics model based on multi-sequence MR images for predicting preoperative immunoscore in rectal cancer

  2022cites this paper
• Mismatch repair proteins expression and tumor-infiltrating T-cells in colorectal cancer

  2022cites this paper
• Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma

  2022cites this paper
• CRC: A Darwinian model of cellular immunoselection

  2022cites this paper
• Diagnostic genes and immune infiltration analysis of colorectal cancer determined by LASSO and SVM machine learning methods: a bioinformatics analysis.

  2022cites this paper
• Interaction between microbiota and immunity and its implication in colorectal cancer

  2022cites this paper
• Single-cell Transcriptomic Architecture Unraveling the Complexity of Tumor Heterogeneity in Distal Cholangiocarcinoma

  2022cites this paper
• Hallmarks of Cancer Applied to Oral and Oropharyngeal Carcinogenesis: A Scoping Review of the Evidence Gaps Found in Published Systematic Reviews

  2022cites this paper
• Programmed death-ligand 1 expression in the immune compartment of colon carcinoma

  2022cites this paper
• Hallmarks of Cancer Expression in Oral Lichen Planus: A Scoping Review of Systematic Reviews and Meta-Analyses

  2022cites this paper
• Interleukin-36α inhibits colorectal cancer metastasis by enhancing the infiltration and activity of CD8+ T lymphocytes.

  2021cites this paper
• Hot or Cold: Bioengineering Immune Contextures into In Vitro Patient-Derived Tumor Models.

  2021cites this paper
• Skoring Prognostik Survival Pasien Triple Negative Breast Cancer Berbasis Immunoscore

  2021cites this paper
• Stimulus-responsive gold nanotheranostic platforms for targeting the tumor microenvironment

  2021cites this paper
• Protagonist of Immuno-Profiling, Immuno-Scoring, and Immunotherapy Towards Colitis-Associated Cancer

  2021cites this paper
• Advances in Digital Pathology: From Artificial Intelligence to Label-Free Imaging

  2021cites this paper
• Understanding the immuno-biology of oesophageal adenocarcinoma: Towards improved therapeutic approaches.

  2021cites this paper
• Texture Analysis of Tumor and Peritumoral Tissues Based on 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Hybrid Imaging in Patients With Rectal Cancer

  2021cites this paper
• Advances in immune therapies for the treatment of microsatellite instability-high/deficient mismatch repair metastatic colorectal cancer (Review)

  2021cites this paper
• Aldehyde Dehydrogenase 2 Mediates Alcohol‐Induced Colorectal Cancer Immune Escape through Stabilizing PD‐L1 Expression

  2021cites this paper
• A Prognosis Marker SLC2A3 Correlates With EMT and Immune Signature in Colorectal Cancer

  2021cites this paper
• Sustainable Clinical Development of Adjuvant Chemotherapy for Colon Cancer

  2021cites this paper
• Immuno-modulating Mediators of Colon Cancer as Immuno-therapeutic: Mechanism and Potential

  2021cites this paper
• N6-Methyladenosine RNA Modification: An Emerging Immunotherapeutic Approach to Turning Up Cold Tumors

  2021cites this paper